Unlock instant, AI-driven research and patent intelligence for your innovation.

Chimeric antigen receptor and its gene and recombinant expression vector, car138-nkt cell and its preparation method and application

A chimeric antigen receptor, NKT cell technology, applied in the field of tumor biological products, can solve the problems of restricting targeted therapy of malignant tumors, non-specific killing effect of target cells, specific killing activity needs to be improved, etc., and achieves good industrial application prospects, Enhance the effect of specific killing activity

Inactive Publication Date: 2019-08-06
GENERAL HOSPITAL OF PLA
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in the process of antibody-dependent cell-mediated killing, since the antibody can specifically bind to the corresponding epitope on the target cell, NKT cells can kill any target cell that has been bound to the antibody, so the antibody and the target cell Antigen binding is specific, but the killing effect of NKT cells on target cells is non-specific
In addition, under normal circumstances, the half-life of infused NKT cells in the patient's body is about 2 weeks, and the validity period is short, requiring repeated infusions
Moreover, NKT cells themselves lack specific antibodies, which are not enough to enrich around tumors or in tumor nests, which restricts the targeted therapy of NKT cells for malignant tumors.
Furthermore, studies have shown that NKT cells do not have a killing effect on all tumors, and the killing effect on some tumors is relatively weak, and the specific killing activity needs to be improved. The immune surveillance of NKT cells on tumor stem cells is still controversial

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chimeric antigen receptor and its gene and recombinant expression vector, car138-nkt cell and its preparation method and application
  • Chimeric antigen receptor and its gene and recombinant expression vector, car138-nkt cell and its preparation method and application
  • Chimeric antigen receptor and its gene and recombinant expression vector, car138-nkt cell and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0028] The method for preparing the lentiviral expression vector pWPXL-CD138ScFv-CD8-CD137-CD3ζ is not particularly limited, and can be various methods conceivable by those skilled in the art. Preferably, the lentiviral expression vector pWPXL-CD138ScFv-CD8-CD137 -The preparation method of CD3ζ comprises the following steps:

[0029] (1) The hinge region and transmembrane region of CD8, the intracellular signaling domain of CD137 and the intracellular signaling domain of CD3ζ were respectively amplified from NKT cell cDNA, and cloned into the vector pWPXL-GFP to construct pWPXL-CD8 - CD137-CD3ζ;

[0030] (2) Synthesize the nucleotide sequence encoding rat growth hormone signal peptide and CD138ScFv, and clone it into pWPXL-CD8-CD137-CD3ζ, and obtain pWPXL-CD138ScFv-CD8-CD137-CD3ζ with the correct sequence after sequencing verification.

[0031] In step (1), there is no particular limitation on the methods for respectively amplifying the hinge region and transmembrane region o...

Embodiment 1

[0083] Example 1 Preparation of NKT cells

[0084] (1) Take human venous blood in a vacuum tube containing heparin. Mononuclear cells (PBMCs) were obtained by density gradient centrifugation using lymphocyte separation medium.

[0085] (2) After PBMCs were washed three times, the final concentration of cells was adjusted to 2×10 by using NKT cell culture medium GT-T551 containing 0.6 volume % human autologous serum. 6 cells / mL; the cells were inoculated on a 75 cm 2 in cell culture flasks. Then add recombinant human interleukin-2 with a final concentration of 500U / mL, 50ng / ml CD3 monoclonal antibody and 50ng / mL recombinant human interleukin-15 to the culture medium, at 37°C and saturated humidity of 5% CO 2 cultured in an incubator.

[0086] (3) On the 4th day of culture, transfer the cells to an uncoated culture flask, add NKT cell culture medium GT-T551 every 2 days according to the number of cell growth, and control the cell concentration to 1×10 8 cells / mL, and added ...

Embodiment 2

[0087] Example 2 Construction of lentiviral expression vector pWPXL-CD138ScFv-CD8-CD137-CD3ζ

[0088] (1) Preparation of NKT cell cDNA

[0089] The NKT cells cultured in Example 1 were centrifuged to precipitate, and the total RNA of the cells was extracted with the total RNA extraction kit RNAisoReagent, and stored at -80°C for future use. Extracted total RNA with RevertAid Reverse Transcription Kit TM NKT cell cDNA was obtained by reverse transcription with First Strand cDNASynthesis Kit, and stored at -20°C for future use.

[0090] (2) Preparation of lentiviral plasmid pWPXL-CD8-CD137-CD3ζ

[0091] The following primer sequences were designed and synthesized (wherein, the underline marks are protected bases, and the square boxes are enzyme cleavage sites):

[0092]

[0093] Using the cDNA of NKT cells in step (1) as a template, PCR amplification was carried out with primers P1 and P2 to obtain the hinge region and transmembrane region of CD8 with a length of 287 bp. T...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a chimeric antigen receptor, a gene and a recombinant expression vector thereof, a CARHER1-NKT cell and a preparation method and application thereof. The chimeric antigen receptor is CD138ScFv-CD8-CD137-CD3 zeta, and comprises a rat growth hormone signal peptide, CD138ScFv, a hinge region and a transmembrane domain of CD8, an intracellular signaling structural domain of CD137 and an intracellular signaling structural domain of CD3 zeta, which are in series connection. The CAR138-NKT cells and CD138 positive myeloma cells are co-cultured to reach specific killing activity on myeloma cells.

Description

technical field [0001] The invention belongs to the field of tumor biological products, and in particular relates to a chimeric antigen receptor CD138ScFv-CD8-CD137-CD3ζ in adoptive immunotherapy, its gene and recombinant expression vector, and engineered CD138-targeted NKT cells (CAR138 -NKT cell) and its preparation method and application. Background technique [0002] Natural killer cells (NKT) are a special type of T lymphocyte subsets with dual properties of T cells and NK cells. NKT cells can express TCR of T cells and NKR-P1 of NK cells. Under the mediation of TCR and NKR, NKT cells can produce a large amount of IL-4 and INFγ, which can kill tumor cells. NKT cells bind to the Fc region of specific antibodies through CD16 on their surface to exert antibody-dependent cell-mediated cytotoxicity (ADCC, antibody-dependent cell-mediated cytotoxicity). However, in the process of antibody-dependent cell-mediated killing, since the antibody can specifically bind to the corre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00C12N15/62C12N15/867C12N5/10A61K39/00A61P35/00
Inventor 韩为东伍志强代汉仁王瑶王晓慧刘洋
Owner GENERAL HOSPITAL OF PLA